✦ LIBER ✦

Clinical relevance of urokinase-type plasminogen activator (uPA) and its inhibitor PAI-1 in oral squamous cell carcinoma (OSCC)

✍ Scribed by H.-F. Zeilhofer; K.P. Bock; P. Dettmar; B. Hundsdorfer; K. Ulm; R. Sader; H.-H. Horch; H. Höfler; M. Schmitt

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Clinical relevance of urokinase-type pla

✍ LC Horn; S Pippig; G Raptis; U Fischer; U Köhler; B Hentschel; R Martin 📂 Article 📅 2002 🏛 Wiley (Blackwell Publishing) 🌐 English ⚖ 86 KB

Urokinase-type plasminogen activator (uP

✍ P Strojan; M Budihna; L Šmid; I Vrhovec; J Škrk 📂 Article 📅 1998 🏛 Elsevier Science 🌐 English ⚖ 88 KB

Expression of Urokinase-Type Plasminogen

✍ Sarah A. Andres; Angelena B. Edwards; James L. Wittliff 📂 Article 📅 2012 🏛 John Wiley and Sons 🌐 English ⚖ 835 KB

Role of urokinase-type plasminogen activ

✍ E. Steiner; K. Pollow; D. Hasenclever; W. Schormann; M. Hermes; M. Schmidt; A. P 📂 Article 📅 2008 🏛 Elsevier Science 🌐 English ⚖ 799 KB

Prognostic significance of urokinase pla

✍ D Vrbanec; S Jelisavac-Cosic; J Jakic-Razumovic; E Mustac; I Kuzmic-Prusac 📂 Article 📅 2004 🏛 Elsevier Science 🌐 English ⚖ 331 KB

Clinical Relevance of Urokinase-Type Pla

✍ Coşkun Tecimer; David L. Doering; L.Jane Goldsmith; John S. Meyer; Gazi Abdulhay 📂 Article 📅 2001 🏛 Elsevier Science 🌐 English ⚖ 67 KB